JUDITH SEGALL
Profile
First Name
: JUDITH
Middle Name
:
Last Name
: SEGALL
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
FRANKLIN M. BERGER, NEAL C BRADSHER, ARNOLD I BURNS, ROBERT N BUTLER, ABRAHAM E COHEN, STEPHEN C. FARRELL, WALTER FUNK, VALETA GREGG, VALETA A GREGG, ALFRED D KINGSLEY, PEDRO LICHTINGER, HENRY L. NORDHOFF, ROBERT W PEABODY, STEVEN A SEINBERG, HAL STERNBERG, WILLIAM P. TEW, GREGG VALETA, ANDREW C. VON ESCHENBACH, HAROLD WAITZ, MICHAEL D WEST
DIRECTOR, EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2015-02-09
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2014-06-16
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
Equity
2014-06-09
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2014-03-04
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2011-03-21
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2011-01-28
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2010-05-07
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2010-04-27
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2009-05-13
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity, Debt
2009-04-15
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2009-05-13
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity, Debt
2009-04-15
